Logo image of NLOK

NORTONLIFELOCK INC (NLOK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NLOK - US6687711084 - Common Stock

21.66 USD
-0.5 (-2.26%)
Last: 11/7/2022, 8:00:02 PM
21.66 USD
0 (0%)
After Hours: 11/7/2022, 8:00:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NLOK. NLOK was compared to 276 industry peers in the Software industry. NLOK has a bad profitability rating. Also its financial health evaluation is rather negative. NLOK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NLOK was profitable.
In the past year NLOK had a positive cash flow from operations.
NLOK Yearly Net Income VS EBIT VS OCF VS FCFNLOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 1B 2B 3B

1.2 Ratios

Industry RankSector Rank
ROA 3.72%
ROE 34.81%
ROIC 5.9%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NLOK Yearly ROA, ROE, ROICNLOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 10K 20K 30K

1.3 Margins

NLOK's Profit Margin has improved in the last couple of years.
NLOK's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 33.52%
PM (TTM) 20.57%
GM N/A
OM growth 3Y33.91%
OM growth 5Y53.81%
PM growth 3Y187.2%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NLOK Yearly Profit, Operating, Gross MarginsNLOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 50 100 150

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NLOK is destroying value.
Compared to 1 year ago, NLOK has more shares outstanding
The debt/assets ratio for NLOK has been reduced compared to a year ago.
NLOK Yearly Shares OutstandingNLOK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M
NLOK Yearly Total Debt VS Total AssetsNLOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.75, we must say that NLOK is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of NLOK is 12.98, which is on the high side as it means it would take NLOK, 12.98 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 5.82 is on the high side and indicates that NLOK has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 5.82
Debt/FCF 12.98
Altman-Z 0.75
ROIC/WACC0.8
WACC7.39%
NLOK Yearly LT Debt VS Equity VS FCFNLOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 0.57 indicates that NLOK may have some problems paying its short term obligations.
A Quick Ratio of 0.57 indicates that NLOK may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.57
NLOK Yearly Current Assets VS Current LiabilitesNLOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B

More info and screens

4

3. Growth

3.1 Past

NLOK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.43%, which is quite good.
NLOK shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.02% yearly.
Looking at the last year, NLOK shows a small growth in Revenue. The Revenue has grown by 6.84% in the last year.
The Revenue has been decreasing by -7.00% on average over the past years.
EPS 1Y (TTM)10.43%
EPS 3Y3.25%
EPS 5Y8.02%
EPS Q2Q%4.65%
Revenue 1Y (TTM)6.84%
Revenue growth 3Y4.42%
Revenue growth 5Y-7%
Sales Q2Q%8.09%

3.2 Future

NLOK is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.98% yearly.
The Revenue is expected to grow by 4.64% on average over the next years.
EPS Next Y6.2%
EPS Next 2Y7.23%
EPS Next 3Y8.03%
EPS Next 5Y7.98%
Revenue Next Year5.5%
Revenue Next 2Y6.79%
Revenue Next 3Y6.75%
Revenue Next 5Y4.64%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NLOK Yearly Revenue VS EstimatesNLOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
NLOK Yearly EPS VS EstimatesNLOK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.03, which indicates a correct valuation of NLOK.
When comparing the Price/Earnings ratio of NLOK to the average of the S&P500 Index (26.51), we can say NLOK is valued rather cheaply.
A Price/Forward Earnings ratio of 10.76 indicates a reasonable valuation of NLOK.
NLOK is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.03
Fwd PE 10.76
NLOK Price Earnings VS Forward Price EarningsNLOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF 18.47
EV/EBITDA 20.97
NLOK Per share dataNLOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)1.94
PEG (5Y)1.5
EPS Next 2Y7.23%
EPS Next 3Y8.03%

More info and screens

3

5. Dividend

5.1 Amount

NLOK has a Yearly Dividend Yield of 2.26%.
Compared to an average S&P500 Dividend Yield of 2.00, NLOK has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

On average, the dividend of NLOK grows each year by 18.56%, which is quite nice.
NLOK has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)18.56%
Div Incr YearsN/A
Div Non Decr YearsN/A
NLOK Yearly Dividends per shareNLOK Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

NLOK pays out 50.59% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of NLOK is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP50.59%
EPS Next 2Y7.23%
EPS Next 3Y8.03%
NLOK Yearly Income VS Free CF VS DividendNLOK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 0 2B 4B 6B
NLOK Dividend Payout.NLOK Dividend Payout, showing the Payout Ratio.NLOK Dividend Payout.PayoutRetained Earnings

More info and screens

NORTONLIFELOCK INC

NASDAQ:NLOK (11/7/2022, 8:00:02 PM)

After market: 21.66 0 (0%)

21.66

-0.5 (-2.26%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-08 2022-11-08/amc
Earnings (Next)02-01 2023-02-01
Inst Owners79.11%
Inst Owner Change0.49%
Ins Owners0.22%
Ins Owner Change0%
Market Cap14.32B
Revenue(TTM)2.87B
Net Income(TTM)591.00M
Analysts76.92
Price Target27.07 (24.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly Dividend0.5
Dividend Growth(5Y)18.56%
DP50.59%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.46%
Min EPS beat(2)-6.13%
Max EPS beat(2)-4.78%
EPS beat(4)1
Avg EPS beat(4)-3.45%
Min EPS beat(4)-6.13%
Max EPS beat(4)0.97%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.97%
Min Revenue beat(2)-17.57%
Max Revenue beat(2)-14.37%
Revenue beat(4)0
Avg Revenue beat(4)-13%
Min Revenue beat(4)-17.57%
Max Revenue beat(4)-4.92%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.03
Fwd PE 10.76
P/S 4.98
P/FCF 18.47
P/OCF 18.29
P/B 8.43
P/tB N/A
EV/EBITDA 20.97
EPS(TTM)1.8
EY8.31%
EPS(NY)2.01
Fwd EY9.29%
FCF(TTM)1.17
FCFY5.41%
OCF(TTM)1.18
OCFY5.47%
SpS4.35
BVpS2.57
TBVpS-17.79
PEG (NY)1.94
PEG (5Y)1.5
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 34.81%
ROCE N/A
ROIC 5.9%
ROICexc 6.44%
ROICexgc N/A
OM 33.52%
PM (TTM) 20.57%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y33.91%
OM growth 5Y53.81%
PM growth 3Y187.2%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 5.82
Debt/FCF 12.98
Debt/EBITDA N/A
Cap/Depr 5.44%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 131.13%
Current Ratio 0.57
Quick Ratio 0.57
Altman-Z 0.75
F-Score4
WACC7.39%
ROIC/WACC0.8
Cap/Depr(3y)10.98%
Cap/Depr(5y)17.76%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.43%
EPS 3Y3.25%
EPS 5Y8.02%
EPS Q2Q%4.65%
EPS Next Y6.2%
EPS Next 2Y7.23%
EPS Next 3Y8.03%
EPS Next 5Y7.98%
Revenue 1Y (TTM)6.84%
Revenue growth 3Y4.42%
Revenue growth 5Y-7%
Sales Q2Q%8.09%
Revenue Next Year5.5%
Revenue Next 2Y6.79%
Revenue Next 3Y6.75%
Revenue Next 5Y4.64%
EBIT growth 1Y-16.26%
EBIT growth 3Y39.82%
EBIT growth 5Y43.04%
EBIT Next Year11.19%
EBIT Next 3Y9.61%
EBIT Next 5Y6.54%
FCF growth 1Y158.45%
FCF growth 3Y-9.08%
FCF growth 5YN/A
OCF growth 1Y159.77%
OCF growth 3Y-13.31%
OCF growth 5YN/A

NORTONLIFELOCK INC / NLOK FAQ

What is the ChartMill fundamental rating of NORTONLIFELOCK INC (NLOK) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NLOK.


Can you provide the valuation status for NORTONLIFELOCK INC?

ChartMill assigns a valuation rating of 3 / 10 to NORTONLIFELOCK INC (NLOK). This can be considered as Overvalued.


Can you provide the profitability details for NORTONLIFELOCK INC?

NORTONLIFELOCK INC (NLOK) has a profitability rating of 7 / 10.


What are the PE and PB ratios of NORTONLIFELOCK INC (NLOK) stock?

The Price/Earnings (PE) ratio for NORTONLIFELOCK INC (NLOK) is 12.03 and the Price/Book (PB) ratio is 8.43.


Can you provide the financial health for NLOK stock?

The financial health rating of NORTONLIFELOCK INC (NLOK) is 1 / 10.